AstraZeneca’s New Head Of Strategic Planning & Business Development John Goddard: An Interview With “The Pink Sheet” DAILY (Part 1 of 2)
This article was originally published in The Pink Sheet Daily
Executive Summary
AstraZeneca will become “more proactive” in seeking licensing deals, Goddard says.
You may also be interested in...
AstraZeneca Hits Anti-Infective Target With Arrow Acquisition
Acquisition of U.K. biotech reflects AstraZeneca's core therapeutic focus in infection, the company says.
AstraZeneca Hits Anti-Infective Target With Arrow Acquisition
Acquisition of U.K. biotech reflects AstraZeneca's core therapeutic focus in infection, the company says.
Genentech VP-Business Development Joseph McCracken: An Interview With "The Pink Sheet" DAILY (Part 2 of 2)
Partnership with Roche has been the "ultimate win/win deal," McCracken says.